What is the current size of the drug discovery informatics market?

The market stands at USD 2.97 billion in 2025 and is projected to grow to USD 4.81 billion by 2030 at a 10.11% CAGR. Read More

Which function generates the most revenue?

Sequencing and target data analysis contributes 35.67% of 2024 revenue, reflecting its role in genomics-driven discovery. Read More

What geographic region is expanding the fastest?

Asia-Pacific leads growth with a forecast 14.20% CAGR, driven by China’s regulatory reforms and rising licensing activity. Read More

Why are CROs gaining traction in this space?

Sponsors outsource specialized analytics and data management to CROs, giving the segment a 12.56% CAGR through 2030. Read More

How does AI change drug discovery timelines?

AI-enabled platforms can compress early-stage discovery from 10-15 years to as little as 6-8 years by streamlining target identification and lead optimization. Read More

What is the biggest barrier to adoption?

A shortage of skilled informatics professionals, cited by 83% of pharma companies, remains the primary constraint on scaling deployments. Read More

Drug Discovery Informatics Companies

This report lists the top Drug Discovery Informatics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Drug Discovery Informatics industry.